Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Carcinoma, Hepatocellular"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 50233
Tytuł:
Can MRI features predict clinically relevant hepatocellular carcinoma genetic subtypes?
Autorzy:
Liu X; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. .; Joint Department of Medical Imaging, University Medical Imaging Toronto, University Health Network, University of Toronto, Toronto, ON, Canada. .
Guo Y; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Zhao L; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Misdraji J; Department of Pathology, Yale New Haven Hospital, Yale Medical School, New Haven, CT, USA.
Kapur T; Harvard Medical School, Boston, MA, USA.
Abrams TA; Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Shyn PB; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
Abdominal radiology (New York) [Abdom Radiol (NY)] 2023 Jun; Vol. 48 (6), pp. 1955-1964. Date of Electronic Publication: 2023 Mar 18.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
Humans ; Retrospective Studies ; Contrast Media ; Magnetic Resonance Imaging/methods ; Sensitivity and Specificity ; Gadolinium DTPA
Czasopismo naukowe
Szczegóły
Tytuł:
Balloon-occluded transarterial chemoembolization versus conventional transarterial chemoembolization for the treatment of single hepatocellular carcinoma: a propensity score matching analysis.
Autorzy:
Chu HH; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Gwon DI; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea. .; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-Gil, Songpa-Gu, Seoul, 05505, Republic of Korea. .
Kim GH; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Kim JH; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Ko GY; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Shin JH; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Ko HK; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Yoon HK; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2023 Apr; Vol. 33 (4), pp. 2655-2664. Date of Electronic Publication: 2022 Dec 06.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/therapy
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/therapy
Liver Neoplasms*/pathology
Chemoembolization, Therapeutic*
Humans ; Retrospective Studies ; Propensity Score ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region.
Autorzy:
Kim DY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Toan BN; Clinical Pathology Department, Medic Center, Ho Chi Minh, Vietnam.
Tan CK; Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore.
Hasan I; Faculty of Medicine, University Indonesia/Ciptomangunkusumo Hospital, Jakarta, Indonesia.
Setiawan L; Clinical Pathology Department, Integrated Laboratory, Dharmais National Cancer Hospital, Jakarta, Indonesia.
Yu ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital; College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-sen University, Koahsiung, Taiwan.
Izumi N; Japanese Red Cross Musashino Hospital, Musashino, Japan.
Huyen NN; National Hospital for Tropical Diseases, Hanoi, Vietnam.
Chow PK; Department of Hepato-pancreato-biliary and Transplant Surgery, National Cancer Center Singapore and Singapore General Hospital, Singapore.; Surgery Academic Clinical Program, Duke-NUS Medical School, Singapore.
Mohamed R; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Chan SL; State Key Laboratory of Oncology in South China, Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong.
Tanwandee T; Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Lee TY; Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Medicine, School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Hai TTN; National Hospital for Tropical Diseases, Hanoi, Vietnam.; Biochemistry Department, Hanoi Medical University, Hanoi, Vietnam.
Yang T; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Navy Medical University), Shanghai, China.
Lee WC; Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Chan HLY; Department of Internal Medicine, The Chinese University of Hong Kong and Union Hospital, Hong Kong.
Pokaż więcej
Źródło:
Clinical and molecular hepatology [Clin Mol Hepatol] 2023 Apr; Vol. 29 (2), pp. 277-292. Date of Electronic Publication: 2023 Jan 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/diagnosis
Liver Neoplasms*/pathology
Humans ; alpha-Fetoproteins ; Vitamins ; Biomarkers ; Prothrombin/metabolism ; Vitamin K ; Biomarkers, Tumor
Czasopismo naukowe
Szczegóły
Tytuł:
Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.
Autorzy:
Dong ZR; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Department of General Surgery, Qilu Hospital, Shandong University, Jinan, 250012, China; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, 200032, China. Electronic address: .
Cai JB; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, 200032, China.
Shi GM; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, 200032, China.
Yang YF; Department of General Surgery, Qilu Hospital, Shandong University, Jinan, 250012, China.
Huang XY; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, 200032, China.
Zhang C; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, 200032, China.
Dong RZ; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, 200032, China.
Wei CY; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, 200032, China.
Li T; Department of General Surgery, Qilu Hospital, Shandong University, Jinan, 250012, China. Electronic address: .
Ke AW; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, 200032, China. Electronic address: .
Fan J; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, 200032, China. Electronic address: .
Pokaż więcej
Źródło:
Cancer letters [Cancer Lett] 2023 Jun 28; Vol. 564, pp. 216186. Date of Electronic Publication: 2023 Apr 25.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/therapy
Carcinoma, Hepatocellular*/metabolism
Liver Neoplasms*/genetics
Liver Neoplasms*/therapy
Liver Neoplasms*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
Animals ; Mice ; CD8-Positive T-Lymphocytes/metabolism ; Mice, Inbred C57BL ; Immunotherapy ; Carcinogenesis/genetics ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Cell Line, Tumor
Czasopismo naukowe
Szczegóły
Tytuł:
Metal-organic framework decorated with glycyrrhetinic acid conjugated chitosan as a pH-responsive nanocarrier for targeted drug delivery.
Autorzy:
Cui L; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China; Haihe Laboratory of Modern Chinese Medicine, Tianjin 301617, P.R. China; Tianjin Key Laboratory of TCM Chemistry and Analysis, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
Wang X; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China; Haihe Laboratory of Modern Chinese Medicine, Tianjin 301617, P.R. China.
Liu Z; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China; Haihe Laboratory of Modern Chinese Medicine, Tianjin 301617, P.R. China; Tianjin Key Laboratory of TCM Chemistry and Analysis, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
Li Z; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China; Haihe Laboratory of Modern Chinese Medicine, Tianjin 301617, P.R. China; Tianjin Key Laboratory of TCM Chemistry and Analysis, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
Bai Z; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China; Haihe Laboratory of Modern Chinese Medicine, Tianjin 301617, P.R. China; Tianjin Key Laboratory of TCM Chemistry and Analysis, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
Lin K; Analytical Instrumentation Centre, Tianjin University, Tianjin 300072, P.R. China.
Yang J; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China; Haihe Laboratory of Modern Chinese Medicine, Tianjin 301617, P.R. China.
Cui Y; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China. Electronic address: .
Tian F; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China; Haihe Laboratory of Modern Chinese Medicine, Tianjin 301617, P.R. China; Tianjin Key Laboratory of TCM Chemistry and Analysis, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China. Electronic address: .
Pokaż więcej
Źródło:
International journal of biological macromolecules [Int J Biol Macromol] 2023 Jun 15; Vol. 240, pp. 124370. Date of Electronic Publication: 2023 Apr 11.
Typ publikacji:
Journal Article
MeSH Terms:
Metal-Organic Frameworks*
Chitosan*/chemistry
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/pathology
Glycyrrhetinic Acid*/chemistry
Liver Neoplasms*/drug therapy
Liver Neoplasms*/pathology
Nanoparticles*/chemistry
Humans ; Drug Delivery Systems ; Doxorubicin/chemistry ; Hydrogen-Ion Concentration ; Drug Liberation ; Drug Carriers/therapeutic use ; Tumor Microenvironment
Czasopismo naukowe
Szczegóły
Tytuł:
Are patients with hepatocellular carcinoma and portal vein tumour thrombosis candidates for liver transplantation?
Autorzy:
Soin A; Medanta Institute of Liver Transplantation and Regenerative Medicine, Gurgaon, India.
Lesurtel M; Department of HPB Surgery & Liver Transplantation, APHP Beaujon Hospital, University of Paris Cité, 100, bd General Leclerc, 92110 Clichy, France.
Bhangui P; Medanta Institute of Liver Transplantation and Regenerative Medicine, Gurgaon, India.
Cocchi L; Department of HPB Surgery & Liver Transplantation, APHP Beaujon Hospital, University of Paris Cité, 100, bd General Leclerc, 92110 Clichy, France.
Bouattour M; Department of Hepatology, APHP Beaujon Hospital, University of Paris Cité, 100, Bd General Leclerc, 92110 Clichy, France.
Clavien PA; Department of Surgery and Transplantation, University of Zurich, Switzerland. Electronic address: .
Pokaż więcej
Źródło:
Journal of hepatology [J Hepatol] 2023 Jun; Vol. 78 (6), pp. 1124-1129.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Hepatocellular*/complications
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/complications
Liver Neoplasms*/surgery
Liver Transplantation*/methods
Venous Thrombosis*/etiology
Venous Thrombosis*/surgery
Humans ; Portal Vein/pathology ; Neoplasm Staging ; Treatment Outcome ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
A case of hepatocellular carcinoma with "pseudoprogression" followed by complete response to atezolizumab plus bevacizumab.
Autorzy:
Odagiri N; Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.
Tamori A; Department of Internal Medicine, Kashiwara Municipal Hospital, 1-7-9 Hozenji, Kashiwara City, Osaka, 582-0005, Japan. .
Kotani K; Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.
Motoyama H; Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.
Kawamura E; Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.
Hagihara A; Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.
Fujii H; Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.
Uchida-Kobayashi S; Department of Premier Preventive Medicine, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.
Enomoto M; Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.
Kawada N; Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, 545-8585, Japan.
Pokaż więcej
Źródło:
Clinical journal of gastroenterology [Clin J Gastroenterol] 2023 Jun; Vol. 16 (3), pp. 392-396. Date of Electronic Publication: 2023 Feb 05.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/drug therapy
Chemoembolization, Therapeutic*/methods
Male ; Humans ; Middle Aged ; Bevacizumab/therapeutic use ; Treatment Outcome ; Biomarkers, Tumor
Czasopismo naukowe
Szczegóły
Tytuł:
Simultaneous tumor identification, cholangiography, and securing surgical margin for recurrence of hepatocellular carcinoma using the Medical Imaging Projection System.
Autorzy:
Tashiro Y; Department of General and Gastroenterological Surgery, Showa University School of Medicine, Tokyo, 142-8666, Japan.
Aoki T; Department of General and Gastroenterological Surgery, Showa University School of Medicine, Tokyo, 142-8666, Japan. Electronic address: .
Kusano T; Department of General and Gastroenterological Surgery, Showa University School of Medicine, Tokyo, 142-8666, Japan.
Matsuda K; Department of General and Gastroenterological Surgery, Showa University School of Medicine, Tokyo, 142-8666, Japan.
Pokaż więcej
Źródło:
Surgical oncology [Surg Oncol] 2023 Jun; Vol. 48, pp. 101938. Date of Electronic Publication: 2023 Mar 31.
Typ publikacji:
Case Reports; Video-Audio Media
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Male ; Humans ; Aged ; Margins of Excision ; Coloring Agents ; Indocyanine Green ; Hepatectomy/methods ; Cholangiography ; Tomography, X-Ray Computed
Raport
Szczegóły
Tytuł:
Histone methylation in pre-cancerous liver diseases and hepatocellular carcinoma: recent overview.
Autorzy:
Charidemou E; Department of Biological Sciences, University of Cyprus, 2109, Nicosia, Cyprus.
Koufaris C; Department of Biological Sciences, University of Cyprus, 2109, Nicosia, Cyprus.
Louca M; Department of Biological Sciences, University of Cyprus, 2109, Nicosia, Cyprus.
Kirmizis A; Department of Biological Sciences, University of Cyprus, 2109, Nicosia, Cyprus. .
Rubio-Tomás T; School of Medicine, University of Crete, 70013, Herakleion, Greece. .
Pokaż więcej
Źródło:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Jun; Vol. 25 (6), pp. 1594-1605. Date of Electronic Publication: 2023 Jan 17.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
Adult ; Humans ; Methylation ; Histones/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Nomogram Estimating Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma From Preoperative Gadoxetate Disodium-Enhanced MRI.
Autorzy:
Chen FM; Department of Interventional Radiology, the First Affiliated Hospital of Soochow University, Suzhou, China.; Department of Radiology, the Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, China.
Du M; Department of Pathology, the First Affiliated Hospital of Soochow University, Suzhou, China.
Qi X; Department of Pathology, the Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, China.
Bian L; Department of Radiology, the Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, China.
Wu D; Department of Radiology, the Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, China.
Zhang SL; Department of Radiology, the Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, China.
Wang J; Department of Hepatobiliary Surgery, Xingtai Institute of Cancer Control, the Affiliated Xingtai People's Hospital of Hebei Medical University, Xingtai, China.
Zhou Y; Department of Hepatobiliary Surgery, the Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, China.
Zhu X; Department of Interventional Radiology, the First Affiliated Hospital of Soochow University, Suzhou, China.
Pokaż więcej
Źródło:
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2023 Jun; Vol. 57 (6), pp. 1893-1905. Date of Electronic Publication: 2022 Oct 19.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/surgery
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Humans ; Nomograms ; Retrospective Studies ; Magnetic Resonance Imaging/methods
Czasopismo naukowe
Szczegóły
Tytuł:
Overexpression of CASC19 contributes to tumor progression and predicts poor prognosis after radical resection in hepatocellular carcinoma.
Autorzy:
Hou Y; Blood Transfusion Department, Dalian Municipal Central Hospital, Dalian, Liaoning 116033, China.
Tang Y; Hepatobiliary Surgery Department, Dalian Municipal Central Hospital, No. 826 Southwest Road, Dalian, Liaoning 116033, China.
Ma C; Hepatobiliary Surgery Department, Dalian Municipal Central Hospital, No. 826 Southwest Road, Dalian, Liaoning 116033, China.
Yu J; Hepatobiliary Surgery Department, Dalian Municipal Central Hospital, No. 826 Southwest Road, Dalian, Liaoning 116033, China.
Jia Y; Hepatobiliary Surgery Department, Dalian Municipal Central Hospital, No. 826 Southwest Road, Dalian, Liaoning 116033, China. Electronic address: jiayp_.
Pokaż więcej
Źródło:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2023 Jun; Vol. 55 (6), pp. 799-806. Date of Electronic Publication: 2023 Feb 17.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/surgery
Carcinoma, Hepatocellular*/metabolism
Liver Neoplasms*/genetics
Liver Neoplasms*/surgery
Liver Neoplasms*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Humans ; Cell Line, Tumor ; Neoplasm Recurrence, Local/genetics ; Prognosis ; Cell Proliferation/genetics ; Cell Movement/genetics ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Szczegóły
Tytuł:
Updates on LI-RADS Treatment Response Criteria for Hepatocellular Carcinoma: Focusing on MRI.
Autorzy:
Patel R; Department of Radiology, Stanford, California, USA.
Aslam A; Department of Radiology, University of Michigan Medicine, Ann Arbor, Michigan, USA.
Parikh ND; Department of Internal Medicine, University of Michigan Medicine, Ann Arbor, Michigan, USA.
Mervak B; Department of Radiology, University of Michigan Medicine, Ann Arbor, Michigan, USA.
Mubarak E; Department of Radiology, University of Michigan Medicine, Ann Arbor, Michigan, USA.
Higgins L; Department of Radiology, University of Michigan Medicine, Ann Arbor, Michigan, USA.
Lala K; Department of Radiology, University of Michigan Medicine, Ann Arbor, Michigan, USA.
Conner JF; Department of Radiology, University of Toledo Medical Center, Toledo, Ohio, USA.
Khaykin V; Department of Radiology and Hepatology, University of Michigan Medicine, Michigan, USA.
Bashir M; Department of Radiology, Duke University Medical Center, Durham, North Carolina, USA.
Do RKG; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Burke LMB; Department of Radiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
Smith EN; Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Kim CY; Department of Radiology, Duke University Medical Center, Durham, North Carolina, USA.
Shampain KL; Department of Radiology, University of Michigan Medicine, Ann Arbor, Michigan, USA.
Owen D; Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Mendiratta-Lala M; Department of Radiology, University of Michigan Medicine, Ann Arbor, Michigan, USA.
Pokaż więcej
Źródło:
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2023 Jun; Vol. 57 (6), pp. 1641-1654. Date of Electronic Publication: 2023 Mar 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/radiotherapy
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/radiotherapy
Humans ; Data Systems ; Magnetic Resonance Imaging/methods ; Retrospective Studies ; Contrast Media ; Sensitivity and Specificity
Czasopismo naukowe
Szczegóły
Tytuł:
Integrative computational modeling to unravel novel potential biomarkers in hepatocellular carcinoma.
Autorzy:
Walakira A; Centre for Functional Genomics and Bio-Chips, Institute for Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. Electronic address: .
Skubic C; Centre for Functional Genomics and Bio-Chips, Institute for Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Nadižar N; Centre for Functional Genomics and Bio-Chips, Institute for Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Rozman D; Centre for Functional Genomics and Bio-Chips, Institute for Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Režen T; Centre for Functional Genomics and Bio-Chips, Institute for Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Mraz M; Faculty of Computer and Information Science, University of Ljubljana, Ljubljana, Slovenia.
Moškon M; Faculty of Computer and Information Science, University of Ljubljana, Ljubljana, Slovenia. Electronic address: .
Pokaż więcej
Źródło:
Computers in biology and medicine [Comput Biol Med] 2023 Jun; Vol. 159, pp. 106957. Date of Electronic Publication: 2023 Apr 20.
Typ publikacji:
Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
Humans ; Gene Regulatory Networks ; Gene Expression Profiling ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Computer Simulation ; Computational Biology ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Szczegóły
Tytuł:
Prognostic implication of early posttransplant hypercholesterolemia in liver transplantation for patients with hepatocellular carcinoma.
Autorzy:
Wei RL; Department of Hepatobiliary and Pancreatic Surgery, The Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Institute of Organ Transplantation, Zhejiang University, Hangzhou 310003, China.
Fan GH; Department of Hepatobiliary and Pancreatic Surgery, The Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Institute of Organ Transplantation, Zhejiang University, Hangzhou 310003, China.
Zhang CZ; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Institute of Organ Transplantation, Zhejiang University, Hangzhou 310003, China.
Chen KC; Department of Hepatobiliary and Pancreatic Surgery, The Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China; Institute of Organ Transplantation, Zhejiang University, Hangzhou 310003, China.
Zhang WH; Department of Hepatobiliary and Pancreatic Surgery, The Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Institute of Organ Transplantation, Zhejiang University, Hangzhou 310003, China.
Li CB; Department of Hepatobiliary and Pancreatic Surgery, The Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Institute of Organ Transplantation, Zhejiang University, Hangzhou 310003, China.
Dong SY; National Center for Healthcare Quality Management in Liver Transplant, Hangzhou 310003, China.
Chen JL; National Center for Healthcare Quality Management in Liver Transplant, Hangzhou 310003, China.
Ling SB; Department of Hepatobiliary and Pancreatic Surgery, The Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China; Institute of Organ Transplantation, Zhejiang University, Hangzhou 310003, China.
Zheng SS; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Institute of Organ Transplantation, Zhejiang University, Hangzhou 310003, China; National Center for Healthcare Quality Management in Liver Transplant, Hangzhou 310003, China; Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital, Hangzhou 310022, China.
Xu X; Department of Hepatobiliary and Pancreatic Surgery, The Center for Integrated Oncology and Precision Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Institute of Organ Transplantation, Zhejiang University, Hangzhou 310003, China; National Center for Healthcare Quality Management in Liver Transplant, Hangzhou 310003, China. Electronic address: .
Pokaż więcej
Źródło:
Hepatobiliary & pancreatic diseases international : HBPD INT [Hepatobiliary Pancreat Dis Int] 2023 Jun; Vol. 22 (3), pp. 228-238. Date of Electronic Publication: 2022 May 17.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/etiology
Carcinoma, Hepatocellular*/surgery
Liver Transplantation*/adverse effects
Liver Neoplasms*/pathology
Hypercholesterolemia*/complications
Hypercholesterolemia*/diagnosis
Hyperlipidemias*
Humans ; Prognosis ; Retrospective Studies ; Neoplasm Recurrence, Local/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
Ferroptosis signaling promotes the release of misfolded proteins via exosomes to rescue ER stress in hepatocellular carcinoma.
Autorzy:
Yang J; Department of Medical Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China.
Xu H; Department of Medical Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China.
Wu W; West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China.
Huang H; Department of Medical Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China.
Zhang C; Department of Medical Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China.
Tang W; Department of Medical Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China.
Tang Q; Department of Medical Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China.
Bi F; Department of Medical Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China. Electronic address: .
Pokaż więcej
Źródło:
Free radical biology & medicine [Free Radic Biol Med] 2023 Jun; Vol. 202, pp. 110-120. Date of Electronic Publication: 2023 Mar 29.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Ferroptosis*/genetics
Exosomes*
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
Humans ; Endoplasmic Reticulum Stress/physiology
Czasopismo naukowe
Szczegóły
Tytuł:
Editorial for "Nomogram Estimating Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma From Preoperative Gadoxetate Disodium-Enhanced MRI".
Autorzy:
Lee DH; Department of Radiology, Seoul National University Hospital, Seoul, Korea.
Pokaż więcej
Źródło:
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2023 Jun; Vol. 57 (6), pp. 1906-1907. Date of Electronic Publication: 2022 Oct 25.
Typ publikacji:
Editorial
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/surgery
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Humans ; Nomograms ; Gadolinium DTPA ; Magnetic Resonance Imaging ; Contrast Media ; Retrospective Studies
Opinia redakcyjna
Szczegóły
Tytuł:
Genetic variants of SOS2, MAP2K1 and RASGRF2 in the RAS pathway genes predict survival of HBV-related hepatocellular carcinoma patients.
Autorzy:
Lin Q; Department of Clinical Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Qiu M; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.
Wei X; School of Public Health, Guangxi Medical University, Nanning, China.
Xiang Z; School of Public Health, Guangxi Medical University, Nanning, China.
Zhou Z; Department of Cancer Prevention and Control, Guangxi Medical University Cancer Hospital, Nanning, China.
Ji I; Department of Scientific Research Dept, Guangxi Medical University Cancer Hospital, Nanning, China.
Liang X; Department of Disease Process Management, Guangxi Medical University Cancer Hospital, Nanning, China.
Zhou X; Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Wen Q; Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Liu Y; Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China. .; Key Cultivated Laboratory of Cancer Molecular Medicine, Health Commission of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China. .
Yu H; Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China. .; Key Cultivated Laboratory of Cancer Molecular Medicine, Health Commission of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China. .; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Guangxi Medical University, Ministry of Education, Nanning, China. .
Pokaż więcej
Źródło:
Archives of toxicology [Arch Toxicol] 2023 Jun; Vol. 97 (6), pp. 1599-1611. Date of Electronic Publication: 2023 Apr 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
Humans ; Hepatitis B virus/genetics ; Genotype ; Alleles ; Polymorphism, Single Nucleotide ; Genetic Predisposition to Disease ; MAP Kinase Kinase 1/genetics ; ras Guanine Nucleotide Exchange Factors/genetics
Czasopismo naukowe
Szczegóły
Tytuł:
Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data.
Autorzy:
Zhang J; Department of Radiology, Eastern Hepatobilliary Surgery Hospital, Third Affiliated Hospital of Naval Medical University, Shanghai 200438, China.
Dong W; Department of Pathology, Eastern Hepatobilliary Surgery Hospital, Third Affiliated Hospital of Naval Medical University, Shanghai 200438, China.
Li Y; School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Fu J; Department of Organ Transplantation, Changhai Hospital, First Affiliated Hospital of Naval Medical University, Shanghai 200433, China. Electronic address: .
Jia N; Department of Radiology, Eastern Hepatobilliary Surgery Hospital, Third Affiliated Hospital of Naval Medical University, Shanghai 200438, China. Electronic address: .
Pokaż więcej
Źródło:
European journal of radiology [Eur J Radiol] 2023 Jun; Vol. 163, pp. 110839. Date of Electronic Publication: 2023 Apr 20.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/surgery
Carcinoma, Hepatocellular*/blood supply
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Liver Neoplasms*/blood supply
Cholangiocarcinoma*/diagnostic imaging
Cholangiocarcinoma*/surgery
Hepatitis B*
Bile Duct Neoplasms*/diagnostic imaging
Bile Duct Neoplasms*/surgery
Humans ; Male ; Adult ; Middle Aged ; Female ; Retrospective Studies ; Neoplasm Invasiveness/diagnostic imaging ; Neoplasm Invasiveness/pathology ; Bile Ducts, Intrahepatic/pathology ; Tomography, X-Ray Computed ; Magnetic Resonance Imaging/methods
Czasopismo naukowe
Szczegóły
Tytuł:
Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study.
Autorzy:
Prabhakar T; Department of Clinical Epidemiology, Institute of Liver and Biliary Sciences, New Delhi, India.
Kaushal K; Department of Clinical Epidemiology, Institute of Liver and Biliary Sciences, New Delhi, India.
Prasad M; Department of Clinical Epidemiology, Institute of Liver and Biliary Sciences, New Delhi, India.
Gupta E; Department of Virology, Institute of Liver and Biliary Science, New Delhi, India.
Sood A; Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India.
Jain AK; Department of Gastroenterology, Choithram Hospital and Research Centre, Indore, India.
Shukla A; Department of Gastroenterology, GS Medical College and KEM Hospital, Mumbai, India.
Goel A; Department of Hepatology, Christian Medical College, Vellore, India.
Duseja A; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Saraya A; Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Shah S; Department of Transplant Hepatology, HPB, Liver Intensive Care, Global Hospital, Mumbai, India.
Kumar G; Department of Biostatistics, Institute of Liver and Biliary Sciences, New Delhi, India.
Sarin SK; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India. .
Pokaż więcej
Źródło:
Hepatology international [Hepatol Int] 2023 Jun; Vol. 17 (3), pp. 745-752. Date of Electronic Publication: 2023 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/etiology
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/epidemiology
Liver Neoplasms*/etiology
Liver Neoplasms*/pathology
Non-alcoholic Fatty Liver Disease*/pathology
Hepatitis B*/complications
Humans ; Male ; Middle Aged ; Aged ; Female ; Liver Cirrhosis/etiology ; Liver Cirrhosis/complications ; Fibrosis ; Risk Factors
Czasopismo naukowe
Szczegóły
Tytuł:
Imaging of pediatric liver tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
Autorzy:
Schooler GR; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Infante JC; Department of Radiology, Nemours Children's Health, Orlando, Florida, USA.
Acord M; Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Alazraki A; Department of Radiology and Imaging Sciences, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Chavhan GB; Department of Diagnostic Imaging, Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
Davis JC; Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Khanna G; Department of Radiology and Imaging Sciences, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Morani AC; Singleton Department of Radiology, Texas Children's Hospital, Houston, Texas, USA.; Department of Radiology, Baylor College of Medicine, Houston, Texas, USA.
Morin CE; Department of Radiology, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Nguyen HN; Singleton Department of Radiology, Texas Children's Hospital, Houston, Texas, USA.; Department of Radiology, Baylor College of Medicine, Houston, Texas, USA.
Rees MA; Department of Radiology, Nationwide Children's Hospital, Columbus, Ohio, USA.
Shaikh R; Department of Radiology, Boston Children's Hospital, Boston, Massachusetts, USA.
Srinivasan A; Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Squires JH; Department of Radiology, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Tang E; Department of Radiology, Seattle Children's Hospital, Seattle, Washington, USA.
Thacker PG; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Towbin AJ; Department of Radiology, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Jun; Vol. 70 Suppl 4, pp. e29965. Date of Electronic Publication: 2022 Sep 14.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/pathology
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/epidemiology
Hepatoblastoma*/diagnostic imaging
Hepatoblastoma*/pathology
Child ; Humans ; Child, Preschool ; Surface Plasmon Resonance ; Diagnostic Imaging
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 50233

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies